IL-10 increases the number of CFU-GM generated by ex vivo expansion of unmanipulated human MNCs and selected CD34+ cells

Transfusion

Volumn 41, Issue 5, 2001, Pages 659-666

  Wagner, Thomas ^a,b,c   Fritsch, Gerhard ^a,b,c   Thalhammer, Renate ^a,b,c   Höcker, Paul ^a,b,c   Lanzer, Gerhard ^a,b,c   Lechner, Klaus ^a,b,c   Geissler, Klaus ^a,b,c  

^a University Clinic Graz   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 3;

ARTICLE; CANCER; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CELL SUSPENSION; COLONY FORMING UNIT GM; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKAPHERESIS; LYMPHOMA; PROMYELOCYTE; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; LEUKAPHERESIS; LEUKOCYTES, MONONUCLEAR;

EID: 0034851155     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41050659.x     Document Type: Article

References (56)

1. An unusual pattern of hematopoietic reconstitution in patients with acute myeloid leukemia transplanted with autologous recovery phase peripheral blood
2. The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukemia
3. Autologous progenitor cell transplantion: Prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cells but not of bone marrow grafts
4. Comparison of hematological recovery times and supportive care requirements of autologous recovery phase peripheral stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants
5. Recombinant methionyl human stem cell factor (r-met HuSCF) and filgrastim for PBPC mobilization and transplantation in non-Hodgkin's lymphoma patients. Results of a phase I/II trial
6. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy
7. Mobilization of peripheral blood progenitor cells for allogeneic transplantation: Efficacy and toxicity of a high dose rh G-CSF regimen
8. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers
9. High-dose therapy for refractory multiple myeloma: Improved prognosis with better supportive care and double-transplants
10. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer
11. Factors affecting blood stem cell collections following high dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors
12. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy
13. Peripheral blood progenitor mobilization using stem cell factor in combination with filgrastim in breast cancer patients
14. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage
15. Manipulation of the hematopoietic stem cell in vitro
16. Maintenance of transplantation potential in ex vivo expanded CD34+-selected human peripheral blood progenitor cells
17. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo
18. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects
19. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer
20. CD34+ cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity
21. Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems
22. Interleukin-10 increases bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells
23. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
24. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI
25. Functional characterization of IL-10
26. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
27. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction
28. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells
29. Myeloperoxidase expression in CD34+ normal hematopoietic cells
30. Recombinant human interleukin-3 expands the pool of circulating hematopoietic progenitor cells in primates-synergism with recombinant human granulocyte/macrophage colony-stimulating factor
31. Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neutrophil granulocytes and erythroblasts
32. Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantation
33. Quantitative CD34 analysis: Comparison of methods
34. Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: Report from the second nordic workshop
35. Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation
36. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults
37. Interleukin-10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells
38. G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1
39. Immunomagnetic selection of CD34+ cells: Factors influencing component purity and yield
40. Culturing human umbilical cord blood: A comparison of mononuclear vs CD34+ selected cells
41. Effects of CD34+ cell selection and perfusion on ex vivo expansion of peripheral blood mononuclear cells
42. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood. Influences of progenitor enrichment, interferences with feeder layers, early-acting cytokines and agitation of culture vessels
43. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells
44. Expansion in vitro of tranplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-NOD/SCID mice
45. Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer
46. Transplantation of ex vivo expanded cells grown in Aastrom stromal-based perfusion bioreactors from small marrow aliquots (40 mL) produces durable hematopoietic reconstitution after ablative chemotherapy
47. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells
48. Interleukin-10: A cytokine used by tumors to escape immunosurveillance
49. Allogeneic sibling umbilical cord blood transplantation in forty-four children with malignant and non-malignant disease
50. Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease
51. High efficiency retroviral-mediated gene transduction into single isolated immature and replatable CD34+++ hematopoietic stem/progenitor cells from human umbilical cord blood
52. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood
53. Interleukin- 10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release
54. IL-10 inhibits IL-7-mediated murine pre-B cell growth in vitro
55. Influence of IL-10 on murine CFU-pre-B formation
56. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood